Home Cart 0 Sign in  
X

[ CAS No. 31938-07-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 31938-07-5
Chemical Structure| 31938-07-5
Chemical Structure| 31938-07-5
Structure of 31938-07-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 31938-07-5 ]

Related Doc. of [ 31938-07-5 ]

Alternatived Products of [ 31938-07-5 ]

Product Details of [ 31938-07-5 ]

CAS No. :31938-07-5 MDL No. :MFCD00001906
Formula : C8H6BrN Boiling Point : -
Linear Structure Formula :- InChI Key :UUZYFBXKWIQKTF-UHFFFAOYSA-N
M.W : 196.04 Pubchem ID :36023
Synonyms :

Calculated chemistry of [ 31938-07-5 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.66
TPSA : 23.79 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -9.61 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.89
Log Po/w (XLOGP3) : -2.98
Log Po/w (WLOGP) : 2.52
Log Po/w (MLOGP) : 2.52
Log Po/w (SILICOS-IT) : 2.81
Consensus Log Po/w : 1.35

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 0.44
Solubility : 545.0 mg/ml ; 2.78 mol/l
Class : Highly soluble
Log S (Ali) : 3.04
Solubility : 216000.0 mg/ml ; 1100.0 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -3.74
Solubility : 0.0353 mg/ml ; 0.00018 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.35

Safety of [ 31938-07-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302+H312+H332-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 31938-07-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 31938-07-5 ]
  • Downstream synthetic route of [ 31938-07-5 ]

[ 31938-07-5 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 31938-07-5 ]
  • [ 21906-32-1 ]
Reference: [1] Journal of medicinal chemistry, 1970, vol. 13, # 6, p. 1040 - 1042
[2] Patent: US5639780, 1997, A,
  • 2
  • [ 31938-07-5 ]
  • [ 1878-67-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 11, p. 3018 - 3022
[2] Journal fuer Praktische Chemie (Leipzig), 1932, vol. <2> 133, p. 331,346
[3] Journal of the Chemical Society, 1948, p. 1251,1254
[4] Jahresbericht ueber die Fortschritte der Chemie und Verwandter Theile Anderer Wissenschaften, 1880, p. 481
  • 3
  • [ 60312-83-6 ]
  • [ 31938-07-5 ]
Reference: [1] Patent: EP1834953, 2007, A1, . Location in patent: Page/Page column 20
[2] Patent: US2008/21080, 2008, A1, . Location in patent: Page/Page column 17-18
  • 4
  • [ 89598-96-9 ]
  • [ 6011-14-9 ]
  • [ 31938-07-5 ]
Reference: [1] Angewandte Chemie - International Edition, 2014, vol. 53, # 39, p. 10510 - 10514[2] Angew. Chem., 2014, vol. 126, # 39, p. 10678 - 10682,5
  • 5
  • [ 328002-25-1 ]
  • [ 31938-07-5 ]
Reference: [1] Journal of the Chemical Society, 1948, p. 1251,1254
  • 6
  • [ 108-24-7 ]
  • [ 31938-07-5 ]
Reference: [1] Journal of the Chemical Society, 1948, p. 1251,1254
  • 7
  • [ 31938-07-5 ]
  • [ 28229-69-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 11, p. 3018 - 3022
  • 8
  • [ 64-17-5 ]
  • [ 31938-07-5 ]
  • [ 14062-30-7 ]
Reference: [1] Patent: US2570024, 1949, ,
[2] Patent: US2570024, 1949, ,
  • 9
  • [ 31938-07-5 ]
  • [ 58971-11-2 ]
YieldReaction ConditionsOperation in experiment
97% With lithium aluminium tetrahydride; sulfuric acid In tetrahydrofuran at -5 - 20℃; for 2 h; A suspension of LiAlH4 (3.04 g, 80 mmole) in dry THF ( 100 ml) was cooled to -5 0C. Concentrated H2SO4 (3.9 g, 40 mmole) was added dropwise, and the resulting mixture was stirred at -5 0C for 1 hour. A solution of 3-bromo-benzenacetontrile (9.80 g, 50 mmole) in THF (5 ml) was added dropwise, and the reaction was allowed to warm to room temperature when the addition was complete. The reaction was stirred at room temperature for 1 hour, and then cooled back to 0 0C and quenched by the addition of a 1 : 1 THF: H2O mixture (12.4 ml). Et2O was added (50 ml), followed by a 3.6 M solution of NaOH (24.4 ml). The mixture was filtered through Celite, and the solids were washed well with additional Et2O. The organic phase was dried over Na2SO4, filtered, and concentrated in vacuo to provide the title compound (9.7 g, 97percent). The crude compound was used in subsequent steps. 1H NMR (400 MHz, CDCl3) δ 7.38-7.30 (m, 2H), 7.20-7.10 (m, 2H), 2.96 (t, 2H), 2.72 (t, 2H), 1.35 (br s, 2H). MS (ESI) m/z: Calculated: 199; Observed: 200/202 (M++.).
96% With lithium aluminium tetrahydride; sulfuric acid In tetrahydrofuran at 0 - 20℃; for 1 h; A suspension of LIALH4 (1.24 g, 32.7 mmol) in dry THF (50 mL) was cooled to 0 °C. Concentrated H2SO4 (1.6 g, 16.3 mmol) was added dropwise, and the resulting mixture was stirred at 0 °C for 30 min. A solution of 3-bromo- benzeneacetonitrile (4.01 g, 20.4 mmol) in THF (5 mL) was added dropwise, and the reaction was allowed to warm to room temperature when the addition was complete. The reaction was stirred at room temperature for lh, and then cooled back to 0 °C and quenched by the addition of a 1: 1 THF: H20 mixture (5 mL). Et2O was added (20 mL), followed by a 3.6 M solution OF NAOH (10 mL). The mixture was filtered through Celite, and the solids were washed well with additional ET2O. The organic phase was dried over NA2S04, filtered, and concentrated in vacuo to provide the title compound (3.91 g, 96percent). The crude compound was used in subsequent STEPS. 1H- NMR (CDC13); 8 7.38-7. 30 (overlapping s at 7.35 and d, J=7. 2 Hz for d, 2H), 7.20- 7.10 (m, 2H), 2. 96 (t,. J=6. 8 Hz, 2H), 2.72 (t, J=6. 4 Hz, 2H), 1. 35 (br s, 2H). MS (ESI) (M+H) += 200/202.
93% With lithium aluminium tetrahydride; sulfuric acid In tetrahydrofuran at 20℃; for 1 h; A suspension of LiAH4 (2.5 g, 66 mmol, 1.6 eq) in dry THF (100 mL) was cooled to -5° C. and concentrated H2SO4 (3.2 g, 33 mmol, 0.8 eq) was added drop wise while the temperature was maintained below 3° C. The reaction mixture was stirred at 5° C. for 40 minutes and a solution of intermediate I-59 (8.0 g, 41 mmol, 1.0 eq) in THF was added drop wise. The reaction mixture was warmed to room temperature and stirred for additional 60 minutes. The reaction mixture was cooled to 0° C. and quenched by adding a mixture of THF (5 mL) and water (5 mL). Ether was added followed by a solution of sodium hydroxide (20 mL, 3.6M in water) and the crude reaction mixture was filtered through short plug of Celite. The combined organic layers were dried over anhydrous MgSO4, the solids were removed by filtration and the filtrate was concentrated by evaporation to give intermediate I-60 (8.0 g, 93percent). MS (ESI): m/z 200 (M+H+).
93.4% With raney nickel In ethanol at 20℃; for 10 h; Add 300 mL of ethanol to the three-neck bottle.35.0 g of 3-bromophenylacetonitrile and 5.0 g of Raney nickel were reacted at 20 ° C for 10 h.Filter and concentrate the filtrate to give a crude product.Recrystallization from petroleum ether gave 34.7 g (93.4percent) of 3-bromophenylethylamine.
92%
Stage #1: With lithium aluminium tetrahydride; sulfuric acid In tetrahydrofuran at 20℃; for 1 h;
Stage #2: With sodium hydroxide; water In tetrahydrofuran; diethyl ether
Step 1:
2-(3-bromophenyl)ethanamine
To a solution of 2M LAH (31 mL) in THF (37 mL) at 0° C. was added sulfuric acid (1.6 mL) dropwise.
This mixture was allowed to stir for 30 min and then (3-bromophenyl)-acetonitrile (30.6 mmol) in THF (7.5 mL) was slowly added.
The reaction mixture was allowed to warm to rt and stir for 1 hr.
The reaction was cooled to 0° C. and then a 1:1 v:v mixture of THF:water (20 mL) was added, followed by diethyl ether (40 mL).
A precipitate formed.
4N NaOH was added until the solution reached pH=9.
The mixture was filtered and the solid was washed with ether.
The solution was dried over Na2SO4 and concentrated to give 2-(3-bromophenyl)ethanamine (28.1 mmol, 92percent) as an oil, which was used without further purification.
83.3%
Stage #1: With borane-THF In tetrahydrofuran at 0℃; for 24.5 h; Reflux
Stage #2: for 4 h; Reflux
General procedure: Toa solution of 2-bromobenzyl cyanide (20.0 g, 0.1 mol) in THF (100 mL) was added1M BH3·THF (200 mL, 0.2 mol) dropwise at 0 oCover 30 min and then heated to reflux for 24 h. After quenchedwith MeOH (50 mL) and 6M HCl (50 mL) at 0 oC, the reaction mixturewas heated to reflux for another 4 h and concentrated under reduced pressure.The residue was diluted with H2O (300 mL) and washed with EA (75 mL×2). The aqueous layer was then neutralized by 15percent NaOH, extracted with EA (75mL ×2). The combined organic layer was dried over Na2SO4and concentrated under reduced pressure to afford compound 2a as yellow oil (17.4 g, 85.2percent).
73%
Stage #1: With borane-THF In tetrahydrofuranHeating / reflux
Stage #2: With hydrogenchloride; water In tetrahydrofuran at 20℃;
2-(3-Bromophenyl) ethylamine To a solution of 3-bromophenyl acetonitrile (9.8 g, 50 mmol) in THF (20 mL) is added a solution of borane (.1 M in THF, 150 mL) under a nitrogen atmosphere. The reaction mixture is refluxed overnight. It is cooled to room temperature and treated with 6 N HCl (150 mL). The resulting mixture is washed with ethyl acetate and ethyl acetate is discarded. The aqueous layer is basifed with sodium carbonate and then extracted with ethyl acetate several times. The combined organic layer is washed with water, dried over sodium sulfate, and the solvent is removed under reduced pressure to obtain colorless viscous oil without further purification (7.3 g, 73percent).

Reference: [1] Patent: WO2007/61458, 2007, A2, . Location in patent: Page/Page column 44; 78
[2] Patent: WO2004/60882, 2004, A1, . Location in patent: Page 29-30
[3] Patent: US2010/204214, 2010, A1, . Location in patent: Page/Page column 109-110
[4] Patent: CN103880745, 2018, B, . Location in patent: Paragraph 0019; 0020; 0021; 0030; 0039
[5] Patent: US2008/171754, 2008, A1, . Location in patent: Page/Page column 101-102
[6] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 18, p. 3050 - 3056
[7] Patent: WO2008/76954, 2008, A2, . Location in patent: Page/Page column 49
[8] Advanced Synthesis and Catalysis, 2012, vol. 354, # 16, p. 2997 - 3008
  • 10
  • [ 31938-07-5 ]
  • [ 124840-61-5 ]
Reference: [1] Archiv der Pharmazie (Weinheim, Germany), 1989, vol. 322, p. 483 - 487
  • 11
  • [ 31938-07-5 ]
  • [ 364793-86-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 11, p. 3018 - 3022
  • 12
  • [ 31938-07-5 ]
  • [ 893566-74-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 18, p. 3050 - 3056
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 31938-07-5 ]

Aryls

Chemical Structure| 215800-05-8

[ 215800-05-8 ]

2-(4-Bromo-2-methylphenyl)acetonitrile

Similarity: 0.97

Chemical Structure| 188347-48-0

[ 188347-48-0 ]

3,5-Dibromobenzylcyanide

Similarity: 0.94

Chemical Structure| 57775-08-3

[ 57775-08-3 ]

3-(4-Bromophenyl)propanenitrile

Similarity: 0.94

Chemical Structure| 42186-06-1

[ 42186-06-1 ]

2-(4-Bromophenyl)propanenitrile

Similarity: 0.89

Chemical Structure| 925672-89-5

[ 925672-89-5 ]

4-Bromo-2-cyanobenzeneacetonitrile

Similarity: 0.89

Bromides

Chemical Structure| 215800-05-8

[ 215800-05-8 ]

2-(4-Bromo-2-methylphenyl)acetonitrile

Similarity: 0.97

Chemical Structure| 188347-48-0

[ 188347-48-0 ]

3,5-Dibromobenzylcyanide

Similarity: 0.94

Chemical Structure| 57775-08-3

[ 57775-08-3 ]

3-(4-Bromophenyl)propanenitrile

Similarity: 0.94

Chemical Structure| 42186-06-1

[ 42186-06-1 ]

2-(4-Bromophenyl)propanenitrile

Similarity: 0.89

Chemical Structure| 925672-89-5

[ 925672-89-5 ]

4-Bromo-2-cyanobenzeneacetonitrile

Similarity: 0.89

Nitriles

Chemical Structure| 215800-05-8

[ 215800-05-8 ]

2-(4-Bromo-2-methylphenyl)acetonitrile

Similarity: 0.97

Chemical Structure| 188347-48-0

[ 188347-48-0 ]

3,5-Dibromobenzylcyanide

Similarity: 0.94

Chemical Structure| 57775-08-3

[ 57775-08-3 ]

3-(4-Bromophenyl)propanenitrile

Similarity: 0.94

Chemical Structure| 42186-06-1

[ 42186-06-1 ]

2-(4-Bromophenyl)propanenitrile

Similarity: 0.89

Chemical Structure| 925672-89-5

[ 925672-89-5 ]

4-Bromo-2-cyanobenzeneacetonitrile

Similarity: 0.89